American Society of Nephrology

Kidney Compass: Obinutuzumab, REGENCY, & Updates in Lupus Nephritis, With Brad Rovin, MD

ByShikha Wadhwani, MD, MS,Brad Rovin, MD

November 8th 2025

Discover groundbreaking insights on lupus nephritis treatment from the REGENCY trial, highlighting the impact of obintuzumab on patient outcomes.

Richard Johnson, MD | Credit: University of Colorado Anschutz

Pegloticase Plus Methotrexate Shows Hypertension Benefit in Gout Patients, with Richard Johnson, MD

ByPatrick Campbell

November 6th 2023

Richard Johnson, MD, discusses the results of a study from ASN Kidney Week 2023 detailing the effects of urate-lowering therapy on blood pressure among patients with gout.

Samir Parikh, MD | Credit: Ohio State University

Repeat Biopsy Analysis Underlines Safety, Efficacy of Voclosporin in Lupus Nephritis

ByPatrick Campbell

November 5th 2023

An analysis of data from 26 patients with repeat kidney biopsies in the AURORA program suggests voclosporin (Lupkynis) reduces proteinuria without causing harm in lupus nephritis patients.

Urate-Lowering Therapy Could Also Lower Blood Pressure in Gout Patients

ByPatrick Campbell

November 2nd 2023

An analysis of the MIRROR trial from ASN Kidney Week 2023 details the effects of urate-lowering therapy on blood pressure among patients with uncontrolled gout receiving pegloticase plus methotrexate in the phase 4 trial.

Phase 3 Data Provide Evidence of Voclosporin as Long-Term Treatment for Lupus Nephritis

ByGiuliana Grossi

November 3rd 2022

A significantly higher number of patients receiving voclosporin achieved good renal outcome when compared with placebo.